Prophylactic vs Therapeutic Anticoagulation in Symptomatic Isolated Distal Deep Vein Thrombosis
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 480 participants.
Also called NCT04967573
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 480 participants
- Sponsor
- Registry
-
NCT04967573
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT04967573. Randomized; triple masking; primary purpose treatment. Start 2021-08-01 (actual); primary completion 2023-06-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Prophylactic vs Therapeutic Anticoagulation in Symptomatic Isolated Distal Deep Vein Thrombosis
- Condition
- Venous Thrombosis
- Intervention (Drug)
- Rivaroxaban
- Lead sponsor
- Shanghai Zhongshan Hospital
Record details
- Record id
cardio:ct-nct04967573- Content hash
88dc4eaa4d2d899a248bdd2654a013e31e940d422209ee8833a74de729e0e10f